Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of Clorox Co (NYSE: CLX) closed at $127.50 in the last session, down -0.15% from day before closing price of $127.69. In other words, the price has decreased by -$0.15 from its previous closing price. On the day, 1.47 million shares were traded. CLX stock price reached its highest trading level at $128.2 during the session, while it also had its lowest trading level at $126.4.
Ratios:
We take a closer look at CLX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 69.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.62. For the most recent quarter (mrq), Quick Ratio is recorded 0.44 and its Current Ratio is at 0.74. In the meantime, Its Debt-to-Equity ratio is 109.04 whereas as Long-Term Debt/Eq ratio is at 103.89.
On November 06, 2024, TD Cowen Upgraded its rating to Hold which previously was Sell and also upped its target price recommendation from $155 to $170.
Jefferies Upgraded its Hold to Buy on October 01, 2024, whereas the target price for the stock was revised from $174 to $187.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 07 ’25 when Breber Pierre R bought 4,000 shares for $136.57 per share. The transaction valued at 546,285 led to the insider holds 4,000 shares of the business.
Marriner Kirsten sold 7,494 shares of CLX for $1,136,251 on Mar 10 ’25. The EVP – Chief People Officer now owns 27,038 shares after completing the transaction at $151.62 per share. On Mar 11 ’25, another insider, Marriner Kirsten, who serves as the EVP – Chief People Officer of the company, sold 733 shares for $150.00 each. As a result, the insider received 109,950 and left with 26,305 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLX now has a Market Capitalization of 15738090496 and an Enterprise Value of 18595733504. As of this moment, Clorox’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.90, and their Forward P/E ratio for the next fiscal year is 18.72. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.24 while its Price-to-Book (P/B) ratio in mrq is 582.03. Its current Enterprise Value per Revenue stands at 2.649 whereas that against EBITDA is 14.747.
Stock Price History:
The Beta on a monthly basis for CLX is 0.53, which has changed by -0.035698056 over the last 52 weeks, in comparison to a change of 0.11730647 over the same period for the S&P500. Over the past 52 weeks, CLX has reached a high of $171.37, while it has fallen to a 52-week low of $126.99. The 50-Day Moving Average of the stock is -6.98%, while the 200-Day Moving Average is calculated to be -16.97%.
Shares Statistics:
According to the various share statistics, CLX traded on average about 1.60M shares per day over the past 3-months and 1583580 shares per day over the past 10 days. A total of 123.25M shares are outstanding, with a floating share count of 122.85M. Insiders hold about 0.32% of the company’s shares, while institutions hold 83.11% stake in the company. Shares short for CLX as of 1747267200 were 5035306 with a Short Ratio of 3.15, compared to 1744675200 on 3438944. Therefore, it implies a Short% of Shares Outstanding of 5035306 and a Short% of Float of 4.66.
Dividends & Splits
The forward annual dividend rate for CLX is 4.88, which was 4.88 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.03821756The stock’s 5-year Average Dividend Yield is 2.94. The current Payout Ratio is 214.84% for CLX, which recently paid a dividend on 2025-04-23 with an ex-dividend date of 1745366400. Stock splits for the company last occurred on 1999-08-24 when the company split stock in a 2:1 ratio.
Earnings Estimates
Clorox Co (CLX) is presently subject to a detailed evaluation by 16.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $1.54, with high estimates of $2.01 and low estimates of $1.34.
Analysts are recommending an EPS of between $7.21 and $6.85 for the fiscal current year, implying an average EPS of $7.06. EPS for the following year is $6.85, with 19.0 analysts recommending between $7.6 and $6.22.
Revenue Estimates
According to 11 analysts, the current quarter’s revenue is expected to be $1.93B. It ranges from a high estimate of $1.98B to a low estimate of $1.9B. As of the current estimate, Clorox Co’s year-ago sales were $1.9BFor the next quarter, 11 analysts are estimating revenue of $1.59B. There is a high estimate of $1.69B for the next quarter, whereas the lowest estimate is $1.51B.
A total of 17 analysts have provided revenue estimates for CLX’s current fiscal year. The highest revenue estimate was $7.1B, while the lowest revenue estimate was $7.01B, resulting in an average revenue estimate of $7.05B. In the same quarter a year ago, actual revenue was $7.09BBased on 17 analysts’ estimates, the company’s revenue will be $6.98B in the next fiscal year. The high estimate is $7.2B and the low estimate is $6.71B.
